menu
    • menu

    Company profile for NovaBiotics Ltd

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    NovaBiotics Ltd is a leading clinical-stage biotechnology company focused on the design and development of first-in-class anti-infectives for difficult-to-treat, medically unmet diseases. NovaBiotics is developing its robust pipeline of antifungal and antibacterial candidates including NP339 and NP432 derived from its proprietary antimicrobial peptide technology platform. This rational drug design approach enables the developm...
    NovaBiotics Ltd is a leading clinical-stage biotechnology company focused on the design and development of first-in-class anti-infectives for difficult-to-treat, medically unmet diseases. NovaBiotics is developing its robust pipeline of antifungal and antibacterial candidates including NP339 and NP432 derived from its proprietary antimicrobial peptide technology platform. This rational drug design approach enables the development of smaller, simpler and therapeutically viable AMP based on endogenous AMP; the cornerstone of the body’s host defence against microbes.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NovaBiotics Ltdunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Cruickshank Building, Craibstone, Aberdeen, AB21 9TR
    Telephone
    Telephone
    +44 (0)1224 711377
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://novabiotics.co.uk/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/novabiotics-ltd/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/novabiotics

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    NovaBiotics to Present Preclinical Data on NP339 and Sponsor Symposium
    NovaBiotics to Present Preclinical Data on NP339 and Sponsor Symposium

    05 Oct 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/novabiotics-to-present-preclinical-data-on-np339-and-sponsor-symposium-on-new-antifungals-at-upcoming-10th-congress-on-trends-in-medical-mycology-301392331.html

    PRNEWSWIRE
    05 Oct 2021
    Share Share
    North-east life science firm hopes to reduce covid deaths experimental drug
    North-east life science firm hopes to reduce covid deaths experimental drug

    12 Apr 2020

    // Rebecca Buchan PRESSANDJOURNAL

    https://www.pressandjournal.co.uk/fp/news/aberdeen/2140945/north-east-life-science-firm-hopes-to-reduce-coronavirus-deaths-by-repurposing-experimental-drug/

    Rebecca Buchan PRESSANDJOURNAL
    12 Apr 2020
    Share Share
    NovaBiotics given £1.8m to advance Novamycin
    NovaBiotics given £1.8m to advance Novamycin

    19 Feb 2019

    // Anna Smith PHARMATIMES

    http://www.pharmatimes.com/news/novabiotics_given_1.8m_to_advance_novamycin_1278659

    Anna Smith PHARMATIMES
    19 Feb 2019
    Share Share
    Taro Terminates Agreement with NovaBiotics
    Taro Terminates Agreement with NovaBiotics

    28 Sep 2018

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20180928005622/en

    BUSINESSWIRE
    28 Sep 2018
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search